Trial
NCT02862600
Open-Label Study of Perhexiline in Patients With Hypertrophic Cardiomyopathy and Moderate to Severe Heart Failure
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Heart Metabolics Limited
Collaborators
—
Condition
Cardiomyopathy, Hypertrophic
Intervention
Perhexiline
Why stopped
Lack of Efficacy
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-08-31